(6-Isopropoxypyridin-2-yl)boronic acid

Catalog No.: 
ACLKZC710
CAS No.: 
1315350-54-9
Molecular Formula: 
C8H12BNO3
Molecular Weight: 
181
(6-Isopropoxypyridin-2-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$159.00InquiryInquiry
1g95%$493.00InquiryInquiry
5g95%$2416.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(6-Isopropoxypyridin-2-yl)boronic acid
IUPAC Name(6-isopropoxypyridin-2-yl)boronic acid
MDL No.MFCD09607787
Molecular FormulaC8H12BNO3
Molecular Weight181
SMILESCC(OC1=CC=CC(B(O)O)=N1)C
InChI KeyVCMWLHPNTJNJAO-UHFFFAOYSA-N
Synonym6-(ISO-PROPOXY)PYRIDINE-2-BORONIC ACID;(6-Isopropoxypyridin-2-yl)boronic acid;Boronic acid, B-[6-(1-methylethoxy)-2-pyridinyl]-
CAS No.1315350-54-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACLKZC710 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKIQW295 route compound structure diagram
    --
  2. Plus
  3. ACJDZM063 route compound structure diagram
    ACJDZM063652148-90-8In Stock
  4. Then
  5. ACLKZC710 route product structure diagram
    ACLKZC7101315350-54-9
Inquiry

2. ACLKZC710 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKIQW295 route compound structure diagram
    --
  2. Plus
  3. ACTSKX460 route compound structure diagram
    ACTSKX460440680-34-2In Stock
  4. Then
  5. ACLKZC710 route product structure diagram
    ACLKZC7101315350-54-9
Inquiry

3. ACLKZC710 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLKZC710 route product structure diagram
    ACLKZC7101315350-54-9
Inquiry

Comments (0)